НовостиBenzingaGoldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58 Goldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58 Benzinga 2026.10.06 09:35 (GMT+0) Открыть на Benzinga Другие новости